Unlocking the potential of in silico approach in designing antibodies against SARS-CoV-2
Tasshitra R. Subramaniam,
No information about this author
Siti Aisyah Mualif,
No information about this author
Weng Howe Chan
No information about this author
et al.
Frontiers in Bioinformatics,
Journal Year:
2025,
Volume and Issue:
5
Published: Feb. 13, 2025
Antibodies
are
naturally
produced
safeguarding
proteins
that
the
immune
system
generates
to
fight
against
invasive
invaders.
For
centuries,
they
have
been
artificially
and
utilized
eradicate
various
infectious
diseases.
Given
ongoing
threat
posed
by
COVID-19
pandemics
worldwide,
antibodies
become
one
of
most
promising
treatments
prevent
infection
save
millions
lives.
Currently,
in
silico
techniques
provide
an
innovative
approach
for
developing
antibodies,
which
significantly
impacts
formulation
antibodies.
These
develop
with
great
specificity
potency
diseases
such
as
SARS-CoV-2
using
computational
tools
algorithms.
Conventional
methods
designing
frequently
costly
time-consuming.
However,
offers
a
contemporary,
effective,
economical
paradigm
creating
next-generation
especially
accordance
recent
developments
bioinformatics.
By
utilizing
multiple
antibody
databases
high-throughput
approaches,
unique
construct
can
be
designed
,
facilitating
accurate,
reliable,
secure
development
human
use.
Compared
their
traditionally
developed
equivalents,
large
number
-designed
advanced
swiftly
clinical
trials
became
accessible
sooner.
This
article
helps
researchers
more
quickly
affordably
giving
them
access
current
information
on
approaches
creation.
Language: Английский
The Involvement and Manifestations of SARS-CoV-2 Virus in Cardiovascular Pathology
Sofia Teodora Hărșan,
No information about this author
Anca Sin
No information about this author
Medicina,
Journal Year:
2025,
Volume and Issue:
61(5), P. 773 - 773
Published: April 22, 2025
Although
the
acute
phase
of
COVID-19
pandemic
has
subsided,
emergence
post-COVID-19
condition
presents
a
new
and
complex
public
health
challenge,
characterized
by
persistent,
multisystem
symptoms
that
can
endure
for
weeks
or
months
after
initial
infection
with
SARS-CoV-2
virus,
significantly
affecting
survivors’
quality
life.
Among
most
concerning
sequelae
are
cardiovascular
complications,
which
encompass
broad
spectrum
conditions,
including
arrhythmias,
myocardial
damage,
postural
orthostatic
tachycardia
syndrome.
This
narrative
review
explores
burden
on
reviewing
latest
relevant
findings
in
literature
highlighting
different
aspects
COVID-19’s
involvement.
investigates
pathophysiological
mechanisms
underlying
involvement
condition,
focus
direct
viral
invasion
via
ACE2
receptors,
immune-mediated
injury,
cytokine
storm,
systemic
inflammation,
endothelial
dysfunction,
mitochondrial
injury.
The
interplay
between
pre-existing
diseases,
such
as
hypertension,
atherosclerosis,
diabetes,
atrial
fibrillation,
is
also
explored,
revealing
individuals
conditions
at
heightened
risk
both
severe
illness
long-term
complications.
Long-term
immune
activation
persistence
antigens
increasingly
recognized
contributors
to
ongoing
even
mild
asymptomatic
infections.
As
healthcare
system
continues
adapt
consequences
pandemic,
deeper
understanding
these
manifestations
essential.
knowledge
will
inform
development
targeted
strategies
prevention,
clinical
management,
rehabilitation
affected
patients.
Furthermore,
insights
gained
from
intersection
be
instrumental
shaping
responses
future
epidemics,
necessity
multidisciplinary
approaches
patient
care
preparedness.
Language: Английский